GILD · MRNA in the 13F filings
Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.
Holders over time
- GILD
- MRNA
| Quarter | GILD | MRNA |
|---|---|---|
| Q4 2020 | 27 holders, $13.4bn | 16 holders, $4.4bn |
| Q1 2021 | 24 holders, $14.5bn | 18 holders, $8.0bn |
| Q2 2021 | 18 holders, $14.9bn | 22 holders, $18.4bn |
| Q3 2021 | 20 holders, $16.4bn | 27 holders, $27.6bn |
| Q4 2021 | 20 holders, $16.8bn | 20 holders, $17.2bn |
| Q1 2022 | 28 holders, $13.2bn | 16 holders, $11.8bn |
| Q2 2022 | 26 holders, $13.6bn | 19 holders, $10.2bn |
| Q3 2022 | 24 holders, $13.3bn | 22 holders, $8.4bn |
| Q4 2022 | 32 holders, $21.1bn | 20 holders, $13.0bn |
| Q1 2023 | 27 holders, $21.8bn | 17 holders, $11.2bn |
| Q2 2023 | 24 holders, $20.7bn | 15 holders, $8.9bn |
| Q3 2023 | 24 holders, $20.0bn | 12 holders, $7.2bn |
| Q4 2023 | 22 holders, $21.5bn | 8 holders, $6.9bn |
| Q1 2024 | 30 holders, $20.3bn | 7 holders, $7.6bn |
| Q2 2024 | 28 holders, $18.5bn | 13 holders, $9.5bn |
| Q3 2024 | 29 holders, $24.2bn | 12 holders, $4.8bn |
| Q4 2024 | 28 holders, $25.9bn | 15 holders, $3.1bn |
| Q1 2025 | 33 holders, $32.0bn | 11 holders, $2.0bn |
| Q2 2025 | 27 holders, $30.9bn | 10 holders, $2.0bn |
| Q3 2025 | 23 holders, $29.4bn | 9 holders, $1.2bn |
| Q4 2025 | 25 holders, $34.3bn | 10 holders, $2.5bn |
| Q1 2026 | 25 holders, $38.5bn | 9 holders, $4.8bn |
| Q2 2026 | 26 holders, $34.2bn | 9 holders, $8.0bn |
| Q3 2026 | 31 holders, $38.6bn | 17 holders, $22.4bn |
Gilead Sciences Inc
- Holders
- 28
- Reported value
- $25.9bn
- Buyers
- 14
- Sellers
- 14
Breadth 0 among 94 comparable managers.
Moderna Inc
- Holders
- 15
- Reported value
- $3.1bn
- Buyers
- 13
- Sellers
- 3
Breadth +10 among 94 comparable managers.
Who holds both, Q4 2024
Both (9)
Bridgewater Associates LP, D. E. Shaw & Co., Fidelity (FMR LLC), Renaissance Technologies LLC, Tudor Investment Corp, Two Sigma Investments LP, Wellington Management Group LLP, Winton Group Ltd, Woodline Partners LP
Only GILD (19)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Balyasny Asset Management LLC, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, Dodge & Cox, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, PDT Partners LLC, Point72 Asset Management LP, Schonfeld Strategic Advisors LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Verition Fund Management LLC
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.